Development and validation of polygenic risk scores for prediction of breast cancer and breast cancer subtypes in Chinese women. Hou C, Xu B, Hao Y, Yang D, et al. BMC Cancer 2022;22:374.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hou C, Xu B, Hao Y, Yang D, et al. Development and validation of polygenic risk scores for prediction of breast cancer and breast cancer subtypes in Chinese women. BMC Cancer 2022;22:374.
PMID: 35395775